高级搜索
应用组织芯片技术研究IGF-1在反应性和肿瘤性星形胶质细胞中表达的区别[J]. 肿瘤防治研究, 2006, 33(06): 394-396,. DOI: 10.3971/j.issn.1000-8578.2881
引用本文: 应用组织芯片技术研究IGF-1在反应性和肿瘤性星形胶质细胞中表达的区别[J]. 肿瘤防治研究, 2006, 33(06): 394-396,. DOI: 10.3971/j.issn.1000-8578.2881
Expression of IGF-1 in Reactive and Neoplastic Astrocytes: An Immunohistochemical Study Using Tissue Microarray Techniques[J]. Cancer Research on Prevention and Treatment, 2006, 33(06): 394-396,. DOI: 10.3971/j.issn.1000-8578.2881
Citation: Expression of IGF-1 in Reactive and Neoplastic Astrocytes: An Immunohistochemical Study Using Tissue Microarray Techniques[J]. Cancer Research on Prevention and Treatment, 2006, 33(06): 394-396,. DOI: 10.3971/j.issn.1000-8578.2881

应用组织芯片技术研究IGF-1在反应性和肿瘤性星形胶质细胞中表达的区别

Expression of IGF-1 in Reactive and Neoplastic Astrocytes: An Immunohistochemical Study Using Tissue Microarray Techniques

  • 摘要: 目的探讨IGF-1、bcl-2和ki-67蛋白在星形胶质细胞反应性增生与低级别星形胶质细胞瘤中表达的区别及意义。方法应用组织芯片和免疫组化染色技术检测正常脑组织、星形胶质细胞反应性增生、低级别(Ⅰ~Ⅱ级)和高级别(Ⅲ~Ⅳ级)星形胶质细胞瘤中IGF-1、bcl-2和ki-67蛋白的表达情况。结果正常脑组织中三者均为阴性表达;星形胶质细胞反应性增生组中IGF-1、bcl-2和ki-67阳性率分别为28.9%、26.7%、22.2%;低级别星形胶质细胞瘤组中IGF-1、bcl-2和ki-67阳性率分别为63.8%、50.0%、70.2%;高级别星形胶质细胞瘤组中阳性率分别为88.9%、79.2%、95.2%。IGF-1、bcl-2和ki-67在各实验组间比较均差异显著(P<0.01);IGF-1、bcl-2和ki-67表达与组织学分级密切相关(r=0.997、r=0.999和r=0.988,P<0.01);IGF-1与bcl-2、ki-67表达密切相关(r=0.995和r=0.995,P<0.01)。结论IGF-1和bcl-2在星形胶质细胞瘤的发生、发展中起重要作用;IGF-1、bcl-2和ki-67联合应用在星形...

     

    Abstract: Objective To study the difference of IGF-1、bcl-2 and ki-67 protein expression in reactive and neoplastic astrocytes and the significance of them. Methods Immunohistochemistry and tissue microarray techniques were used to determinate the expression of IGF-1、bcl-2 and ki-67 protein in 12 cases of normal brain tissues, 49 cases of astrocytes proliferation, 49 cases of low-grade astrocytomas, and 50 cases of high-grade astrocytomas, 12 cases of normal brain tissues were used as controls. Results The expression ..

     

/

返回文章
返回